Breast Cancer: Performance of prognostic signatures

February 17, 2018 – In a new study, published in JAMA Oncology online on February 15, 2018, a comparison of the performance of 6 prognostic signatures for estrogen receptor (ER) –positive breast cancer was performed in a secondary analysis of a randomized clinical trial.

Read more ›

eHealth: Viz.AI Contact App to alert for stroke in patients

February 15, 2018 – The American Food and Drug Administration (FDA) just permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients.

Read more ›

Placebo: A veritable treatment option

February 11, 2018 – Long after cancer treatment ends, many patients continue to deal with one particular symptom that refuses to go away: fatigue. In a new study, researchers have found that the power of placebos, even when fully disclosed to patients, might be harnessed to reduce fatigue in cancer survivors.

Read more ›

Protection from severe malaria associated with novel genetic polymorphisms

February 04 –Malaria, caused by Plasmodium falciparum parasites, is a major cause of mortality and morbidity in endemic countries of Sub-Saharan Africa with a disproportional burden of 90% of the estimated 212 million annual cases and 92% of 429,000 annual deaths,

Read more ›

Chocolate and the sweet taste receptor gene TAS1R2

January 31, 2018 – Chocolate and the sweet taste receptor gene TAS1R2 may make the life of some obese children and adolescents rather difficult in that genetic variations in TAS1R2 appear related to chocolate powder and dietary fiber intake in these young individuals.

This comes out of a study by a research team at the Faculty of Medicine,

Read more ›

Lutetium 177 dotatate (Lutathera): A treatment for gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

January 29, 2018 – Gastroenteropancreatic neuroendocrine tumors (GEP-NET)s are a rare group of cancers with limited treatment options that affects primarily the pancreas or gastrointestinal tract of patients.  

The American Food &

Read more ›

Is genetic testing of value for ALS patients?

January 19, 2018 – Patients suffering from amyotrophic lateral sclerosis (ALS) find value in genetic testing for the disease, whether or not they have a family history of the condition, according to findings from a survey conducted by U.S. researchers, just published in the November 2017 issue of Molecular Genetics &

Read more ›

Olaparib Tablets (Lynparza): For breast cancer with BRCA gene mutation

January 13, 2018 – The American Food and Drug Administration (FDA) has just approved the first treatment for breast cancer with a certain inherited genetic mutation. At first glance, this announcement may be just one in the series of announcements by the FDA on new drug approvals.

Read more ›

Infidelity: Genetic Factors Link To Cheating

January 05, 2017 – Most don’t do it over the holiday season. Coming January however, they resume what they do and what in many cases is catastrophic for their relationships, marriages, children, and relatives as well: people cheat. At least for bed-hopping women, their infidel behaviour may, at least,

Read more ›

From mice and men: Predicting anti-depressant response

January 01, 2018 – Antidepressants are not at all a “one-size-fits-all pill”. Predicting treatment response in depression in order to get the “right” treatment, efficacious and adverse effects free at the same time, is still a huge challenge. Inter-individual variability to treatment spanning a spectrum from successfully realised clinical response to disastrous self-destructing behaviour up to completed suicide in some individuals is tremendous.

Read more ›

thasso: conditions

thasso post: magazine

View my Flipboard Magazine.

thasso: follow us

thasso: chat

You must be a registered user to participate in this chat.

thasso: tweets

thasso: categories

thasso: archives